NINGBO INNO PHARMCHEM CO.,LTD. is pleased to present a comprehensive look at Phenylacetylglutamine (CAS 28047-15-6), a metabolite with significant implications across various fields of scientific and medical research.

Phenylacetylglutamine is a compound naturally found in human urine, formed by the conjugation of phenylacetate and glutamine. Its primary physiological function involves assisting in the removal of nitrogenous waste from the body, particularly in individuals who may have challenges with the standard urea cycle. This function underscores its importance in phenylacetylglutamine urea cycle support.

One of the most notable applications of Phenylacetylglutamine is its use as a biomarker for metabolic age. Studies have shown a correlation between the levels of Phenylacetylglutamine in urine and an individual's biological age, making it a valuable tool for aging research and understanding age-related metabolic changes. The analysis of phenylacetylglutamine in human urine provides a unique window into these processes.

Beyond its role in aging, Phenylacetylglutamine is also being investigated for its links to kidney health. It is considered a potential phenylacetylglutamine kidney disease indicator, as its elevated levels can be associated with impaired renal function. This highlights its significance in nephrology and diagnostics.

Moreover, Phenylacetylglutamine has connections to cardiovascular health and is studied as a cardiovascular health metabolite. Research is ongoing to understand its precise role in heart disease pathogenesis and its potential as a predictive marker.

As a versatile compound, Phenylacetylglutamine also serves as a valuable phenylacetylglutamine pharmaceutical intermediate. NINGBO INNO PHARMCHEM CO.,LTD. provides high-quality Phenylacetylglutamine to researchers and industries, supporting advancements in metabolic studies, diagnostics, and pharmaceutical development. We are committed to supplying reliable compounds that drive scientific discovery.